help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 51, No. 3 433-437
doi:10.1210/jcem-51-3-433
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CARROLL, B. J.
Right arrow Articles by TARIKA, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CARROLL, B. J.
Right arrow Articles by TARIKA, J.

Plasma Dexamethasone Concentrations and Cortisol Suppression Response in Patients with Endogenous Depression*

BERNARD J. CARROLL, KATHLEEN SCHROEDER, SUNIL MUKHOPADHYAY, JOHN F. GREDEN, MICHAEL FEINBERG, JAMES RITCHIE and JANET TARIKA

Clinical Studies Unit and Mental Health Research Institute, Department of Psychiatry, University of Michigan Ann Arbor, Michigan 48109

Address all correspondence and requests for reprints to: Dr. Bernard J. Carroll, Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan 48109.

An early escape of plasma cortisol concentrations during a 24-h overnight oral dexamethasone suppression test (DST) has been noted in patients with endogenous depression (ED). Among psychiatric patients this finding is highly specific for ED. Plasma dexamethasone and plasma cortisol concentrations were measured in patients with ED and, for comparison, in patients with nonendogenous depression who maintained normal suppression of plasma cortisol during the DST. There was little variation in plasma dexamethasone concentrations between tests within individual patients. In patients with ED tested both before and after treatment the half-life of dexamethasone in plasma between 9-24 h after its administration was the same as that reported by other investigators in normal subjects between 2-8 h after dexamethasone. Abnormally high plasma cortisol concentrations during the DST were observed in patients with ED in association with normal plasma concentrations of dexamethasone. After treatment, these patients maintained normal suppression of plasma cortisol for 24 h after dexamethasone administration, without any change in their plasma dexamethasone concentrations. Patients with nonendogenous depression and those who had recovered from an episode of endogenous depression maintained normal suppression of plasma cortisol through 1600 and 2300 h after dexamethasone despite having low plasma dexamethasone concentrations at these times. We conclude that the abnormal escape of plasma cortisol concentrations from suppression during the 24-h DST in patients with ED cannot be explained by unusually rapid clearance of dexamethasone from plasma. The results indicate that a central neuroendocrine disturbance is present in patients with ED.

* This work was supported by USPHS Grant MH-28294, research funds from the State of Michigan Department of Mental Health, and the Mental Health Research Institute, University of Michigan.

Received January 17, 1980.




This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
R. E. Poland, R. T. Rubin, I. M. Lesser, L. A. Lane, and P. J. Hart
Neuroendocrine Aspects of Primary Endogenous Depression: II. Serum Dexamethasone Concentrations and Hypothalamic-Pituitary-Adrenal Cortical Activity as Determinants of the Dexamethasone Suppression Test Response
Arch Gen Psychiatry, September 1, 1987; 44(9): 790 - 795.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
B. T. Walsh, E. S. Lo, T. Cooper, D. C. Lindy, S. P. Roose, M. Gladis, and A. H. Glassman
Dexamethasone Suppression Test and Plasma Dexamethasone Levels in Bulimia
Arch Gen Psychiatry, September 1, 1987; 44(9): 797 - 800.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
G. W. Arana, R. J. Baldessarini, and M. Ornsteen
The Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arch Gen Psychiatry, December 1, 1985; 42(12): 1193 - 1204.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
C. M. Swartz and F. J. Dunner
Dexamethasone Suppression Testing of Alcoholics
Arch Gen Psychiatry, November 1, 1982; 39(11): 1309 - 1312.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
B. J. Carroll, M. Feinberg, J. F. Greden, J. Tarika, A. A. Albala, R. F. Haskett, N. McI. James, Z. Kronfol, N. Lohr, M. Steiner, et al.
A Specific Laboratory Test for the Diagnosis of Melancholia: Standardization, Validation, and Clinical Utility
Arch Gen Psychiatry, January 1, 1981; 38(1): 15 - 22.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society